Factors of immunodepression in patients with tuberculosis;Facteurs d'immunodépression chez des patients tuberculeux

Presse Medicale

Volumn 34, Issue 6, 2005, Pages 420-424

  Sost, G ^a   Arvieux, C ^b   Cazalets, C ^a   Cador, B ^a   Delaval, P ^b   Michelet, C ^b  

^a SERVICE DE RHUMATOLOGIE   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; QUINOLONE DERIVATIVE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULIN;

ADULT; AGED; ALCOHOLISM; ARTICLE; BACTERIAL VIRULENCE; CHRONIC RESPIRATORY FAILURE; COMPARATIVE STUDY; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE STATUS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PROPHYLAXIS; RETROSPECTIVE STUDY; TUBERCULOSIS; TUBERCULOSIS REACTIVATION;

EID: 16444382270     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(05)83935-1     Document Type: Article

References (25)

1. Chaisson R, Schecter G, Theuer C, Rutherford G, Echenberg D, Hopewell P. Tuberculosis in patients with the acquired immunodeficiency syndrome. Am Rev Respir 1987; 136: 570-4.
2. Dupon M, Ragnaud JM. Tuberculosis in patients infected with human immunodeficiency virus 1. A retrospective multicentre study of 123 cases in France. Q J Med 1992; 306: 719-30.
3. Rieder H, Cauthen G, Bloch A, Cole C, Holtzman D, Snider D et al. Tuberculosis and acquired immunodeficiency syndrome, Florida. Arch Intern Med 1989; 149: 1268-73.
4. Kaplan M, Armstrong D, Rosen P. Tuberculosis complicating neoplastic disease. Cancer 1974; 33: 850-8.
5. Barber T, Sugar A. Mycobacteriosis and nocardiosis in the immunocompromised host. In: Clinical approach to infection in the compromised host (Third Edition). Rubin R, Young Leds. Plenum Medical Book Company, New York, 1994, 239-73.
6. Kim HA, Yoo CD, Baek HJ, Lee EB, Ahn C, Han JS et al. Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population. Clin Exp Rheum 1998; 16: 9-13.
7. Kim SJ, Hong HP, Lew WJ, Yang SC, Lee EG, Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis 1995; 76: 529-33.
8. Iclal I, Bilge BF, Fusun K, Galip G. Pleuropulmonary tuberculosis in patients with end-stage renal disease: findings on chest. Transplant Proc 1999; 31: 1719-20.
9. Aljurf M, Gyger M, Alrajhi A, Sahovic E, Chaudhri N, Musa M et al. Mycobacterium tuberculosis infection in allogenic bone marrow transplantation patients, Bone Marrow Transplant 1999; 24: 551-4.
10. Martino R, Martinez C, Brunet S, Sureda A, Lopez R, Domingo-Albos A. Tuberculosis in bone marrow transplant recipients: report of two cases and review of the litterature, Bone Marrow Transplant 1996; 18: 809-12.
11. Bricaire F, Haas C, Patri B. La tuberculose chez l'immunodé primé. Ann Med Interne 1986; 137: 33841.
12. Dautzenberg B, Grosset J, Fechner J, Lucciani J, Debre P, Herson S et al. The management of thirty immunocompromised patients with tuberculosis. Am Rev Respir Dis 1984; 129: 494-6.
13. Darras-Joly C, Wechsler B, Blettry O, Du LT, Raguin G, Godeau P et al. Tuberculose maladie et maladies systémiques, à propos de 16 cas. Rev Med Interne 1998; 19: 91-7.
14. Skogberg K, Ruutu P, Tukiainen P, Valtonen V. Effect of immunosuppressive therapy on the clinical presentation and outcome of tuberculosis. Clin Infect Dis 1993; 17: 1012-17.
15. Truffot-Pernot C, Cambau E. Le diagnostic bactériologique de la tuberculose. Rev Pneumol Clin 1994; 50: 240-6.
16. Grosset J. Diagnostic bactériologique de la tuberculose. Rev Prat 1996; 46: 1337-43.
17. Grosset J. Place des examens microbiologiques et anatomopathologiques dans la décision diagnostique et thérapeutique. Med Mal Infect 1995; 25: 327-33.
18. Cockerill F, Wilson W, Carpenter H, Smith T, Rosenow E. Open lung biopsy in immunocompromised patients. Arch Intern Med 1985; 145: 1398-404.
19. Bouvet E, Abiteboul D, Antoun F, Bessa Z, Billy C, B Dautzenberg et al. Prévention et prise en charge de la tuberculose en France, synthèse et recommandations du groupe de travail de Conseil supérieur d'hygiène publique de France. Rev Mal Respir 2003; 20: 7S45-7S51.
20. Daucourt V, Petit S, Pasquet S, Portel L, Courty G, Dupon M et al. Comparaison des cas de tuberculose pulmonaire isolée aux cas de tuberculose d'autre localisation dans un système de surveillance active (Gironde, 1995-1996). Rev Med Interne 1998; 19: 792-8.
21. Perronne C, Zahraoui M, Leport C, Salmon D, Pangon B, Bricaire F et al. Tuberculose; chez les malades infectés par le virus de l'immunodéficience humaine, trente observations. Presse Med 1988; 17: 1479-83.
22. Hall C, Willcox P, Swanepoel C, Kahn D, Van Zyl Smit R, Mycobacterial infection in renal transplant recipients. Chest 1994; 106: 435-9.
23. Bass J, Farer L, Hopewell P, Jacobs R. Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986; 134: 355-63.
24. Perronne C. La prophylaxie de la tuberculose chez le sujet immunodéprimé. Ann Med Interne 1997; 148: 226-9.
25. Hong Kong Chest Service, Tuberculosis Research Centre: a double blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Respir Dis 1992; 154: 36-41.